|
Volumn 24, Issue 1, 2004, Pages 217-222
|
The transfection of thymidylate synthase antisense suppresses oncogenic properties of a human colon cancer cell line and augments the antitumor effect of fluorouracil.
a a a a a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC ANTIMETABOLITE;
COMPLEMENTARY DNA;
FLUOROURACIL;
MESSENGER RNA;
THYMIDYLATE SYNTHASE;
ANIMAL;
ARTICLE;
BAGG ALBINO MOUSE;
CELL DIVISION;
CELL SURVIVAL;
COLON TUMOR;
DOSE RESPONSE;
DRUG EFFECT;
DRUG SCREENING;
FEMALE;
GENE EXPRESSION;
GENETIC TRANSFECTION;
GENETICS;
HUMAN;
METABOLISM;
MOUSE;
NUDE MOUSE;
PATHOLOGY;
REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;
TUMOR CELL LINE;
ANIMALS;
ANTIMETABOLITES, ANTINEOPLASTIC;
CELL DIVISION;
CELL LINE, TUMOR;
CELL SURVIVAL;
COLONIC NEOPLASMS;
DNA, ANTISENSE;
DOSE-RESPONSE RELATIONSHIP, DRUG;
FEMALE;
FLUOROURACIL;
GENE EXPRESSION;
HUMANS;
MICE;
MICE, INBRED BALB C;
MICE, NUDE;
REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;
RNA, MESSENGER;
THYMIDYLATE SYNTHASE;
TRANSFECTION;
XENOGRAFT MODEL ANTITUMOR ASSAYS;
MLCS;
MLOWN;
|
EID: 3843101696
PISSN: 10196439
EISSN: None
Source Type: Journal
DOI: 10.3892/ijo.24.1.217 Document Type: Article |
Times cited : (5)
|
References (0)
|